No Data
No Data
Institutional Investors Own a Significant Stake of 48% in Voyager Therapeutics, Inc. (NASDAQ:VYGR)
Wall Street Analysts See a 152.53% Upside in Voyager Therapeutics (VYGR): Can the Stock Really Move This High?
Yun Zhong, PhD, Joins Wedbush Securities as Senior Vice President, Equity Research, Biotechnology
Citigroup Initiates Coverage On Voyager Therapeutics With Buy Rating, Announces Price Target of $12
Voyager Therapeutics Analyst Ratings
Citi Initiates Voyager Therapeutics(VYGR.US) With Buy Rating, Announces Target Price $12
No Data
Space Dust : since mid September.. now in December, patience may be about to pay off.